Cargando…

WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells

Detalles Bibliográficos
Autores principales: Lotti, V., Merigo, F., Lagni, A., Di Clemente, A., Ligozzi, M., Bernardi, P., Rossini, G., Concia, E., Plebani, R., Romano, M., Sbarbati, A., Sorio, C., Gibellini, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184780/
http://dx.doi.org/10.1016/S1569-1993(22)00180-1
_version_ 1784724602887340032
author Lotti, V.
Merigo, F.
Lagni, A.
Di Clemente, A.
Ligozzi, M.
Bernardi, P.
Rossini, G.
Concia, E.
Plebani, R.
Romano, M.
Sbarbati, A.
Sorio, C.
Gibellini, D.
author_facet Lotti, V.
Merigo, F.
Lagni, A.
Di Clemente, A.
Ligozzi, M.
Bernardi, P.
Rossini, G.
Concia, E.
Plebani, R.
Romano, M.
Sbarbati, A.
Sorio, C.
Gibellini, D.
author_sort Lotti, V.
collection PubMed
description
format Online
Article
Text
id pubmed-9184780
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Cystic Fibrosis Society.
record_format MEDLINE/PubMed
spelling pubmed-91847802022-06-10 WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells Lotti, V. Merigo, F. Lagni, A. Di Clemente, A. Ligozzi, M. Bernardi, P. Rossini, G. Concia, E. Plebani, R. Romano, M. Sbarbati, A. Sorio, C. Gibellini, D. J Cyst Fibros Oral Sessions European Cystic Fibrosis Society. 2022-06 2022-06-10 /pmc/articles/PMC9184780/ http://dx.doi.org/10.1016/S1569-1993(22)00180-1 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Oral Sessions
Lotti, V.
Merigo, F.
Lagni, A.
Di Clemente, A.
Ligozzi, M.
Bernardi, P.
Rossini, G.
Concia, E.
Plebani, R.
Romano, M.
Sbarbati, A.
Sorio, C.
Gibellini, D.
WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
title WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
title_full WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
title_fullStr WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
title_full_unstemmed WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
title_short WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
title_sort ws05.04 sars-cov-2 infection is reduced in both immortalised and primary cftr-modulated human bronchial epithelial cells
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184780/
http://dx.doi.org/10.1016/S1569-1993(22)00180-1
work_keys_str_mv AT lottiv ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT merigof ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT lagnia ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT diclementea ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT ligozzim ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT bernardip ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT rossinig ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT conciae ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT plebanir ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT romanom ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT sbarbatia ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT sorioc ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells
AT gibellinid ws0504sarscov2infectionisreducedinbothimmortalisedandprimarycftrmodulatedhumanbronchialepithelialcells